Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population

被引:7
|
作者
Tanash, Hanan [1 ]
Ekstrom, Magnus [2 ]
Basil, Nawfal [1 ]
Ronmark, Eva [3 ]
Lindberg, Anne [4 ]
Piitulainen, Eeva [1 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Resp Med, Lund, Sweden
[2] Lund Univ, Dept Clin Sci Lund, Fac Med, Resp Med & Allergol, Lund, Sweden
[3] Umea Univ, Div Occupat & Environm Med, Dept Publ Hlth & Clin Med, OLIN Unit, Umea, Sweden
[4] Umea Univ, Div Med, Dept Publ Hlth & Clin Med, Umea, Sweden
来源
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020年 / 15卷
关键词
alpha-1-antitrypsin deficiency; chronic obstructive pulmonary disease; ischemic heart disease; smoking; ALPHA(1)-ANTITRYPSIN DEFICIENCY; MORTALITY; AGE; HEALTH;
D O I
10.2147/COPD.S247377
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Severe alpha-1-antitrypsin deficiency (AATD) is an established risk factor for chronic obstructive pulmonary disease (COPD) and liver disease, but the effect on the incidence of ischemic heart disease ( IHD) is not well known. The aim was to evaluate the risk of incident IHD in patients with severe AATD compared with a random sample of the general population, with known smoking habits. Methods: AAT-deficient individuals, phenotype PiZZ (n=1545), were included in the Swedish National AATD Register. Controls (n=5883) were selected from population-based cohorts in Northern Sweden. Data on IHD and comorbidities were obtained by nationwide cross-linkage with the Swedish National Patient Register. Risk factors for incident IHD were analyzed using Cox regression, adjusted for age, gender, smoking status and the presence of COPD, hypertension, hyperlipidemia and diabetes. Results: At inclusion, 46% of the PiZZ individuals and 53% of the controls were neversmokers. During follow-up (median 16 years; range 0.2-23), 8% (n=123) of PiZZ individuals and 12% (n=690) of controls developed IHD. The controls had a significantly higher risk for incident IHD than the PiZZ individuals, with adjusted hazard ratio (HR) of 1.8 (95% CI 1.4-2.3). The risk was higher for controls in both ever-smokers (HR 2.1; 95% CI 1.5-2.9) and never-smokers (HR 1.5; 95% CI 1.1-2.2). Conclusion: PiZZ individuals have a lower risk of developing incident ischemic heart disease than the control subjects with known smoking habits, who had been randomly selected from population-based cohorts.
引用
收藏
页码:1245 / 1252
页数:8
相关论文
共 50 条
  • [1] Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
    Tanash, Hanan A.
    Ekstrom, Magnus
    Ronmark, Eva
    Lindberg, Anne
    Piitulainen, Eeva
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (03)
  • [2] Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
    Hiller, Adriana-Maria
    Ekstrom, Magnus
    Piitulainen, Eeva
    Lindberg, Anne
    Ronmark, Eva
    Tanash, Hanan
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
    Tanash, Hanan A.
    Ekstrom, Magnus
    Wagner, Philippe
    Piitulainen, Eeva
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1663 - 1669
  • [4] Decline in FEV1 related to smoking status in individuals with severe α1-antitrypsin deficiency (PiZZ)
    Piitulainen, E
    Eriksson, S
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (02) : 247 - 251
  • [5] COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency
    Tanash, Hanan
    Blakaj, Erona Tahiri
    Piitulainen, Eeva
    Zaigham, Suneela
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 2661 - 2669
  • [6] Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
    Hanan A Tanash
    Peter M Nilsson
    Jan-Åke Nilsson
    Eeva Piitulainen
    Respiratory Research, 11
  • [7] Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
    Tanash, Hanan A.
    Nilsson, Peter M.
    Nilsson, Jan-Ake
    Piitulainen, Eeva
    RESPIRATORY RESEARCH, 2010, 11
  • [8] Risk of ischemic cerebrovascular disease in α1-antitrypsin deficiency -: Response
    Dahl, M
    Tybjærg-Hansen, A
    Sillesen, H
    Jensen, G
    Steffensen, R
    Nordestgaard, BG
    CIRCULATION, 2003, 108 (08) : E62 - E63
  • [9] A diagnostic algorithm for the identification of individuals at risk for alpha 1-antitrypsin deficiency
    Bomhorst, J.
    Procter, M.
    Meadows, C.
    Ashwood, E. R.
    Mao, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 629 - 629
  • [10] The bronchopulmonary pathology of alpha 1-antitrypsin (AAT) deficiency: Findings of the death review committee of the national registry for individuals with severe deficiency of alpha 1-antitrypsin
    Tomashefski, JF
    Crystal, RG
    Wiedemann, HP
    Mascha, E
    Stoller, JK
    LABORATORY INVESTIGATION, 2003, 83 (01) : 315A - 315A